Frontlight ResearchEarly access
Trial site
Tennessee Oncology, PLLC
- 3running trials
- 5closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer4 trials
- Lung cancer2 trials
- Melanoma1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 34 trials
- Phase 23 trials
- Phase 1/21 trial
- Status
- Completed4 trials
- Active, not recruiting3 trials
- Terminated1 trial
- Lead sponsor
- Pfizer6 trials
- Seagen, a wholly owned subsidiary of Pfizer2 trials
Running trials
Active, not recruiting
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer
Active, not recruiting
Active, not recruiting
A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC
Closed trials
Completed
A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer
Terminated
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026